Vincristine, Dactinomycin, and Cyclophosphamide in Treating Patients With Embryonal Rhabdomyosarcoma

NCT00245089 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Sarcoma

Interventions

BIOLOGICAL: dactinomycin
DRUG: cyclophosphamide
DRUG: vincristine sulfate

Sponsor

Japan Rhabdomyosarcoma Study Group